Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Cabibi

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Thyroid : Official Journal of the American Thyroid Association|August 31, 2007
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangementGiuseppe Pizzolanti, Leonardo Russo, Pierina Richiusa, et al.
Journal of Hepatology|October 27, 2023
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver diseaseFederico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
NPJ Digital Medicine|July 18, 2025
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT modelGiorgio Cazzaniga, Vincenzo L'Imperio, Emanuela Bonoldi, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Life (Basel, Switzerland)|March 28, 2024
Biodistribution Assessment of a Novel <sup>68</sup>Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for AnalysisAnna Maria Pavone, Viviana Benfante, Paolo Giaccone, et al.
Journal of Hepatology|January 5, 2024
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19]Federico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Journal of Clinical Pathology|March 26, 2021
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation studyUmberto Malapelle, Francesco Pepe, Pasquale Pisapia, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Thyroid : Official Journal of the American Thyroid Association|August 31, 2007
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangementGiuseppe Pizzolanti, Leonardo Russo, Pierina Richiusa, et al.
Journal of Hepatology|October 27, 2023
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver diseaseFederico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
NPJ Digital Medicine|July 18, 2025
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT modelGiorgio Cazzaniga, Vincenzo L'Imperio, Emanuela Bonoldi, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Life (Basel, Switzerland)|March 28, 2024
Biodistribution Assessment of a Novel <sup>68</sup>Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for AnalysisAnna Maria Pavone, Viviana Benfante, Paolo Giaccone, et al.
Journal of Hepatology|January 5, 2024
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19]Federico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Journal of Clinical Pathology|March 26, 2021
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation studyUmberto Malapelle, Francesco Pepe, Pasquale Pisapia, et al.
Pageof 13